Net Loss per Share

6 Months Ended

Jun. 30, 2023

Basic and diluted net loss per share attributable to Class A common stockholders and Class B common stockholders (collectively, "Common Stockholders") for the years indicated was calculated as follows:


	Three Months Ended June 30,
	2023		2022
	(in thousands, except per share and share amounts)
Net loss	$	(28,814)	$	(104,362)
Net loss attributable to Common Stockholders	(28,814)		(104,362)
Basic and diluted weighted average number of common shares and common share equivalents outstanding	479,163,752		476,061,809
Net loss per share attributable to Common Stockholders—basic and diluted	$	(0.06)	$	(0.22)


	Six Months Ended June 30,
	2023		2022
	(in thousands, except per share and share amounts)
Net loss	$	(101,420)	$	(179,852)
Net loss attributable to Common Stockholders	(101,420)		(179,852)
Basic and diluted weighted average number of common shares and common share equivalents outstanding	479,819,237		474,553,609
Net loss per share attributable to Common Stockholders—basic and diluted	$	(0.21)	$	(0.38)

Because the Company had a Net loss during the three and six months ended June 30, 2023 and 2022, the Company's potentially dilutive securities, which include stock options, RSUs, PRSUs, preferred stock, and warrants to purchase shares of common stock and preferred stock, have been excluded from the computation of diluted net loss per share, as the effect would be anti-dilutive. Therefore, during these periods, the diluted common shares outstanding equals the average common shares outstanding. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to Common Stockholders for the periods indicated because including them would have had an anti-dilutive effect:


	Three Months Ended June 30,
	2023	2022
Options to purchase common stock	25,504,988	27,966,433
RSUs	54,786,269	32,275,628
PRSUs	31,095,905	27,539,954



Total anti-dilutive shares excluded from computation of net loss per share	111,387,162	87,782,015


	Six Months Ended June 30,
	2023	2022
Options to purchase common stock	25,504,988	27,966,433
RSUs	54,786,269	32,275,628
PRSUs	31,095,905	27,539,954



Total anti-dilutive shares excluded from computation of net loss per share	111,387,162	87,782,015